Anti-fungal shows promise for cancer breakthrough in preclinical tests
An anti-fungal drug shows potential to treat a range of cancers, according to research
from the Repurposing Drugs in Oncology
(ReDO) project, but the drugmakers will need a financial incentive to pursue a licence for new indications.
No comments:
Post a Comment